跳至主要内容
临床试验/DRKS00022923
DRKS00022923已完成未知

Randomized controlled trial to evaluate the digital health application mySugr PRO

Roche Diabetes Care GmbH - DCSDB0 个研究点目标入组 424 人开始时间: 2020年10月22日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
424

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Open (masking not used)

入排标准

年龄范围
16 Years 至 one(—)
性别
All

入选标准

  • ? Diagnosed type 1 diabetes (E10) or type 2 diabetes (E11) or gestational diabetes (O24.4)
  • ? Carrying out regular, daily blood sugar measurements and using the blod glucose values to carry out or adjust diabetes therapy
  • ? Age = 16 years
  • ? Last measured HbA1c value <12% or 107.6 mmol / mol
  • ? Use of a smartphone compatible with the mySugr PRO (Android 5.0 or higher; iOS 11.4 or higher)
  • ? Willingness to consent to the terms and conditions of the mySugr PRO
  • ? Knowledge of spoken and written German
  • ? Given written declaration of consent to participate in the study.
  • For adolescents: a written declaration of consent for participation in the study must be available both from the adolescent himself and from a legal guardian

排除标准

  • ? Use of continuous glucose measurement systems (rtCGM, isCGM)
  • ? Use of a digital diabetes diary or a (diabetes) app for digital therapy documentation in the last 3 months
  • ? Existence of an acute psychiatric illness which, in the opinion of the investigator, impairs the patient's ability to properly carry out the diabetes therapy or the study
  • ? In adults (= 18 years): Lack of consent due to restricted legal capacity or legal support
  • ? Dependency on the sponsor or the clinical investigator (e.g. employees of the sponsor or a test center and their family members)
  • ? Simultaneous participation in another clinical study

研究者

发起方
Roche Diabetes Care GmbH - DCSDB

相似试验